Posts

Christmas Closure Dates

Merry Christmas from the team at NQ Eye Specialists! We will be closed from 12pm on Friday 21st December and will return at 9am on Monday 7th January. Thank you for your ongoing support in 2018. 

$80 million investment in eye medication

The Australian Government will invest $80 million in eye medications through the Pharmaceutical Benefits Scheme (PBS), effect from tomorrow.  Patients who suffer decreased vision as a result of blocked veins in the retina due to a condition known as retinal vein occlusion (RVO) are now able to access subsidised medication which is prescribed by their Ophthalmologist and injected into the eye.  Availability to treatment options such as these are vital to those patients suffering with poor and deteriorating vision due to RVO and other diseases of the eye.  Read more on this exciting news here:  http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt142.htm

AUSCRS 2018

The team at NQ Eye Specialists have been busy attending training with the Australian Society of Cataract and Refractive Surgeons. We were lucky enough to ride the wave in Noosa, to help provide our patients with the best possible outcomes. This conference enabled us to further our professional development with advice from the experts in Cataracts and Refractive surgery along with having the opportunity to engage with ophthalmology companies.

 

 

IPL Treatment for Dry Eye Disease

Dry eye disease is a multifactorial disease that comprises of many different components. Meibomian Gland Dysfunction is a condition where the glands that produce the top layer of your tear film become blocked. When the top layer of the tear film is compromised the tears evaporate, this is called Dry Eye. When the glands become blocked this leads to increased bacteria, leading to increased inflammation.

Intense Pulse Light was initially introduced in advanced Dermatology to treat numerous skin conditions. It has since been proven effective in treating various Dry eye conditions. This method uses brief powerful bursts of light at specific nanometre wavelengths to target change in blood vessels near the surface of the tear film. IPL works by these blood vessels absorbing heat, this mechanism is similar to hot compressing, enabling the pores of the glands to open up. A practitioner will then express the gland to remove the blocking matter. This application has resulted in improved symptoms such as less dryness, decreased use of lubricating eye drops, decrease in redness and foreign body sensation.

For more information please click the link below:

https://onlinelibrary.wiley.com/doi/full/10.1111/cxo.12541

 

Dry eye

Corneal Cross-Linking

Keratoconus is a condition of the Cornea which causes the shape of the Cornea to change from a regular and spherical shape to a more conical shape. Collagen fibres within the cornea usually provide structure and strength to the cornea. In Keratoconus they are abnormal and cause the structure of the cornea to be weakened.  This can cause significant changes to vision, causing symptoms such as blurring of vision and bright lights appearing to be streaked.

NQ Eye Specialists now offer Corneal Collagen Cross-linking. This procedure is used to slow down or halt the progression of Keratoconus.

The procedure is performed under a topical anaesthetic. Firstly, the outer layer of the cornea is removed.  After this, Vitamin B2 drops are applied to the Cornea and the Cornea is then exposed to Ultra Violet light. This process causes a chemical reaction, resulting in an increased number of bonds between collagen fibres resulting in a strengthened Cornea.

Macular Degeneration Week 21-27 May 2018

May 21-27 is Macular Degeneration week. It is a week that allows us to reflect on all Australians suffering with Macula disease. This week increases awareness of all macula diseases including age-related Macular degeneration, Diabetic eye disease and other diseases of the macula. Macular degeneration is responsible for 50% of blindness across the general population. Prevention, detection and diagnosis is the key to achieving optimal eye health. Degeneration of the eye affects a special layer of the cell in the eye called the retinal pigment epithelium (RPE). In later stages of life, the RPE can die this can cause vision loss as there is a lack of blood supply to the eye.

There are two types of macular degeneration, dry and wet. Wet macular degeneration can be treated effectively through intravitreal injections in combination with laser or monotherapy. These do not cure the disease however they focus on maintaining and stabilising vision. Some clinical trials have been used to indicate vision improvement. Dr Goodwin has seen various positive outcomes associated with improved vision from the use of Intravitreal Injections.

For more information on this please click the link below:

https://www.mdfoundation.com.au

World Glaucoma Week 2018

6 things you should know about Glaucoma

Christmas Closure Dates

NQ Eye Specialists will be closed from Friday the 23rd of December 2017 and will reopen on Monday the 8th of January 2018. Thank you for your ongoing support throughout 2017.

We would like to wish you a Merry Christmas and Happy New Year!

World Glaucoma Week 12-18 March 2017

This week is world Glaucoma week to raise awareness for Glaucoma. A condition where the optic nerve at the back of the eye is damaged resulting in permanent vision loss. In the early stages of Glaucoma there are often no symptoms. It is not until the late stages of the disease do those with Glaucoma start to show symptoms. These may include vision loss including a restricted visual field, car parking accidents, decreased contrast detection and an overall decrease in vision that cannot be corrected with spectacles, contact lenses or surgery. It is therefore, highly recommended that the general population receives regular eye examinations to diagnose the disease early before severe visual impairment is reached. Early treatment can significantly reduce the rate and amount of vision loss.

For more information visit Glaucoma Australia.

World Glaucoma Week

Normal visual field

World Glaucoma Week

Glaucoma visual field

What’s new in Glaucoma

Dr Goodwin recently presented to Townsville’s optometrists on the latest in Glaucoma diagnosis and management at NQ Eye Specialists. Dr Goodwin is one of the only surgeons in North Queensland offering MIGS (Micro-Incisional Glaucoma Surgery) . Book an appointment at NQ Eye Specialists to find out if MIGS can help with your Glaucoma.

What is Glaucoma?

Glaucoma is a chronic disease of the eye which can slowly steal our peripheral vision. In most cases this happens so slowly that we don’t even know its happening. It is important to have regular eye health checks with your local optometrist. The optometrist will screen for Glaucoma and will be able to tell if you have the disease in its early stages. By the time you notice the effects of Glaucoma, the disease is likely very severe.

Does Glaucoma run in the family?

Up to 50% of people suffering with Glaucoma will have a family member who also has the disease. Often the family member won’t know they have it. If you have Glaucoma, you should encourage your family to get screened for Glaucoma as well.

What can be done about Glaucoma?

Today we can manage Glaucoma with an increasing number of treatment options . At NQ Eye Specialists we offer medical and laser therapy as well as the latest addition, Micro-Incisional Glaucoma Surgery to treat Glaucoma.

What is MIGS?

MIGS, or Micro-Incisional Glaucoma Surgery, involves that latest available surgical techniques to implant an extremely small device into the Glaucoma drainage part of your eye. The Microstents create better drainage of the fluid from the eye and decrease the pressure inside the eye. In some patients this even means we can do away with Glaucoma eye drops.

How do I find out more about my Glaucoma?

You can find out more about your specific type of Glaucoma and what can be done to help you by making an appointment with NQ Eye Specialists or by phoning us on 1300 856 074.